Lantheus Holdings News, Lantheus Holdings Quote, LNTH Quote

Lantheus Holdings (NQ:LNTH) Delayed: 72.56 -3.75 (4.91%)

Prev. Close

$76.31

Today 6M 1Y 5Y

Open

$75.65

52 Wk High

$10.70

52 Wk Low

$1.76

Day High

$75.65

Day Low

$72.33

P/E

N/A

EPS

$0.00

Volume

1,046,202

Friends, Peers and Foes (?): GEHC, IPN, IPSEY, APLT, SVRA (more...)

ALERTS | RSS

Mar 6, 2026 04:01 PM Lantheus receives FDA approval for PYLARIFY TruVu prostate cancer imaging agent
Mar 6, 2026 04:01 PM Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection
Mar 4, 2026 04:20 PM Form 4 Lantheus Holdings, Inc. For: Mar 02 Filed by: Niedzwiecki Daniel
Mar 4, 2026 04:19 PM Form 4 Lantheus Holdings, Inc. For: Mar 02 Filed by: Morgan Amanda Michelle
Mar 4, 2026 04:19 PM Form 4 Lantheus Holdings, Inc. For: Mar 02 Filed by: Marshall Robert J. Jr.
Mar 4, 2026 04:19 PM Form 4 Lantheus Holdings, Inc. For: Mar 02 Filed by: Heino Mary Anne
Mar 2, 2026 08:32 AM Lantheus receives FDA tentative approval for generic cancer drug
Mar 2, 2026 08:30 AM Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA®
Mar 2, 2026 07:16 AM Lantheus Holdings (LNTH) PT Raised to $89 at Truist Securities
Feb 27, 2026 12:04 PM Lantheus Holdings (LNTH) PT Raised to $89 at Truist Securities

Entities mentioned with LNTH

View All Entities